Diisopropylethylamine → [4-(3,6-Dimethyl-4,10-dihydro-3H-2,3,4,9-tetraaza-benzo[f]azulene-9-carbonyl)-2-fluoro-benzyl]-carbamic Acid Tert-butyl Ester
반응식
[C:1]([O:5][C:6]([NH:8][CH2:9][C:10]1[CH:18]=[CH:17][C:13]([C:14]([OH:16])=O)=[CH:12][C:11]=1[F:19])=[O:7])([CH3:4])([CH3:3])[CH3:2].CCN(C(C)C)C(C)C.[CH3:29][N:30]1[C:39]2[NH:38][C:37]3[CH:40]=[C:41]([CH3:44])[CH:42]=[CH:43][C:36]=3[NH:35][CH2:34][C:33]=2[CH:32]=[N:31]1>CN(C1C=CN=CC=1)C.ClCCl>[C:1]([O:5][C:6](=[O:7])[NH:8][CH2:9][C:10]1[CH:18]=[CH:17][C:13]([C:14]([N:35]2[CH2:34][C:33]3[CH:32]=[N:31][N:30]([CH3:29])[C:39]=3[NH:38][C:37]3[CH:40]=[C:41]([CH3:44])[CH:42]=[CH:43][C:36]2=3)=[O:16])=[CH:12][C:11]=1[F:19])([CH3:2])([CH3:3])[CH3:4]참가 물질
반응물 3
생성물 1
시약·촉매·용매 2
실험 절차
A solution of 4-(tert-butoxycarbonylamino-methyl)-3-fluorobenzoic acid from Example E3.1 (538 mg, 2.0 mmol) and DMAP (220 mg, 1.8 mmol) in dichloromethane (20 ml) at room temperature was treated with DIEA (0.93 ml, 5.4 mmol) and WSCD (460 mg, 2.4 mmol), and the resulting solution was stirred at room temperature for 1 h. 3,6-Dimethyl-3,4,9,10-tetrahydro-2,3,4,9-tetraaza-benzo[f]azulene from Example E2 (385 mg, 1.8 mmol) was added and the resulting solution was heated at reflux for 20 h and allowed to cool to room temperature. The solution was diluted with dichloromethane, washed with saturated NaHCO3 and brine and concentrated in vacuo. The residue was purified by preparative HPLC (eluant 10% methanol:90% dichloromethane) to yield the title compound (265 mg, 32%).
후처리
- customat room temperature
- temperaturethe resulting solution was heated
- temperatureat reflux for 20 h
- temperatureto cool to room temperature
- washwashed with saturated NaHCO3 and brine
- concentrationconcentrated in vacuo
- customThe residue was purified by preparative HPLC (eluant 10% methanol:90% dichloromethane)
출처 및 근거
- ORD 기록
- ord-0ee1672c8ea043fd9d2e8f09f60e17e5
- 출처 데이터셋
- uspto-grants-2012_06
- 특허 번호
- US08202858B2
반응 노트
불러오는 중…